Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for diagnosis, treatment and follow-up of diseases. Given the immense potential impact of nanomedicine on public wellbeing and on economic growth, the field is of considerable strategic importance for Europe.
Based on the success of the EuroNanoMed ERA-NET initiative (2009-2011), support to the European Nanomedecine research community is continuing. The EuroNanoMed II ERA-NET project, comprising 20 partners from 17 countries/regions, has been granted funding through the EC’s 7th Framework Programme. It will run from November 2012 to October 2016.